Which has the lower trailing P/E, ANIP or ETON?

ANIP has the lower trailing P/E: ANIP trades at 15.47 and ETON at 144.49. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ANIP or ETON?

Over the past five years, ETON grew revenue faster — ANIP at a 35.61% CAGR versus ETON at 47.98%.

Is ANIP or ETON more profitable?

ETON runs the higher net margin — ANIP at 10.82% versus ETON at 12.02%.

How have ANIP and ETON total returns compared?

Over the past 5 years, ANIP delivered 16.86% and ETON delivered 63.04% annualized total return. Past performance doesn't predict future results.

ANI Pharmaceuticals, Inc. (ANIP) vs Eton Pharmaceuticals, Inc. (ETON)

A side-by-side comparison of ANI Pharmaceuticals, Inc. and Eton Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANIP

ANI Pharmaceuticals, Inc.

$1.63B

$71.61HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT

ETON

Eton Pharmaceuticals, Inc.

$1.52B

$55.57HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

Total return — ANIP vs ETON

growth of $100 · dividends reinvested · last 8y

ANIP +40.7% (+4.4%/yr)ETON +789.9% (+31.4%/yr)ETON compounded faster over this window

Log scale — wide-divergence pair

ANIP ETON

ANIP vs ETON: by the numbers

•ANIP is the larger company ($1.63B vs $1.52B market cap).
•ANIP trades at the lower trailing earnings multiple (15.47 vs 144.49 P/E), one valuation lens rather than an overall verdict.
•ETON converts more revenue to profit (12.02% vs 10.82% net margin).
•ETON grew revenue faster over the past five years (47.98% vs 35.61% CAGR).

Metrics side by side

Valuation

Metric	ANIP	ETON
P/E ratio	15.47	144.49
Forward P/E	7.72	51.10
P/S ratio	1.66	14.42
P/B ratio	2.73	32.68
EV / EBITDA	6.77	73.10
FCF yield	N/A	0.97%

Profitability

Metric	ANIP	ETON
Gross margin	51.01%	57.87%
Operating margin	15.35%	0.09%
Net margin	10.82%	12.02%
ROE	17.72%	27.24%
ROIC	9.26%	20.41%

Growth (annualized)

Metric	ANIP	ETON
Revenue CAGR (5Y)	35.61%	47.98%
Total return CAGR (5Y)	16.86%	63.04%

Frequently asked

Which has the lower trailing P/E, ANIP or ETON?: ANIP has the lower trailing P/E: ANIP trades at 15.47 and ETON at 144.49. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ANIP or ETON?: Over the past five years, ETON grew revenue faster — ANIP at a 35.61% CAGR versus ETON at 47.98%.
Is ANIP or ETON more profitable?: ETON runs the higher net margin — ANIP at 10.82% versus ETON at 12.02%.
How have ANIP and ETON total returns compared?: Over the past 5 years, ANIP delivered 16.86% and ETON delivered 63.04% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANIP analysis Full ETON analysis Interactive comparison tool

Dig into the metrics

ANI Pharmaceuticals P/E ratio Eton Pharmaceuticals P/E ratio ANI Pharmaceuticals ROE Eton Pharmaceuticals ROE ANI Pharmaceuticals operating margin Eton Pharmaceuticals operating margin ANI Pharmaceuticals revenue growth Eton Pharmaceuticals revenue growth ANI Pharmaceuticals free cash flow Eton Pharmaceuticals free cash flow

ANI Pharmaceuticals & Eton Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.